What is Babatunde Adetunji's specialty?

Babatunde Adetunji (NPI 1326131699) is a Medicare-billing provider whose primary specialty is Neuropsychiatry in Philadelphia, PA.

Where does Babatunde Adetunji practice?

Babatunde Adetunji practices in Philadelphia, PA, based on the location reported in the CMS Medicare provider datasets for NPI 1326131699.

How much does Medicare pay Babatunde Adetunji?

Medicare Part B utilization, prescribing (Part D), MIPS quality scores, and industry payments for Babatunde Adetunji (NPI 1326131699) are detailed on this CareTrace profile.

PROVIDER PROFILE · NPI 1326131699

Babatunde Adetunji

NeuropsychiatryPhiladelphia, PAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

374

Beneficiaries

—

Total drug cost

$81K

Distinct drugs

Brand share

13.9%

Top prescribed drugs

Clonazepam80 claims

Gabapentin54 claims

Clozapine34 claims

Bupropion Hcl28 claims

Fluoxetine Hcl22 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Babatunde Adetunji's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 1 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
FRIENDS BEHAVIORAL HEALTH SYSTEM, LP	18	22

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Gretchen Magnani Psychiatry · Camden, NJ	16	41

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history